|
TBL1X expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89070981093664E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71762604139758E-12 |
| Normal-vs-Stage2 |
1.932270E-02 |
| Normal-vs-Stage3 |
9.44549999992716E-07 |
| Normal-vs-Stage4 |
2.203600E-03 |
| Stage1-vs-Stage2 |
5.571000E-01 |
| Stage1-vs-Stage3 |
8.066400E-01 |
| Stage1-vs-Stage4 |
4.576000E-01 |
| Stage2-vs-Stage3 |
5.057600E-01 |
| Stage2-vs-Stage4 |
3.987800E-01 |
| Stage3-vs-Stage4 |
6.011000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.06845651717913E-12 |
| Normal-vs-AfricanAmerican |
1.43690000009578E-07 |
| Normal-vs-Asian |
3.950100E-02 |
| Caucasian-vs-AfricanAmerican |
9.527600E-01 |
| Caucasian-vs-Asian |
4.081000E-01 |
| AfricanAmerican-vs-Asian |
4.386600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
8.442300E-02 |
| Male-vs-Female |
6.47320000000118E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.3805999999359E-08 |
| Normal-vs-Extreme_Weight |
4.10782519111308E-15 |
| Normal-vs-Obese |
1.91788999999165E-05 |
| Normal-vs-Extreme_Obese |
1.01079999925702E-09 |
| Normal_Weight-vs-Extreme_Weight |
2.498200E-01 |
| Normal_Weight-vs-Obese |
3.707800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.265030E-01 |
| Extreme_Weight-vs-Obese |
3.987900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.730400E-01 |
| Obese-vs-Extreme_Obese |
2.355800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.253840E-02 |
| Normal-vs-Age(41-60Yrs) |
5.2785000004274E-07 |
| Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(81-100Yrs) |
9.69659996741257E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.119200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.074200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.512960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.084390E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.397600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.760400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.49769086021934E-13 |
| Normal-VS-Type2 PRCC |
5.55111512312578E-16 |
| Normal-VS-KIRP CIMP |
2.315200E-01 |
| Normal-VS-Unclassified PRCC |
1.022400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.850000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.101010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.070600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.127600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.896100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.163200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.94490029321082E-10 |
| Normal-vs-N1 |
3.6840000000038E-05 |
| Normal-vs-N2 |
4.350200E-01 |
| N0-vs-N1 |
5.242000E-01 |
| N0-vs-N2 |
3.165600E-01 |
| N1-vs-N2 |
4.944200E-01 |
|
|
